Related Experiment Video
Updated: Dec 14, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
MCM3AP-AS1/miR-876-5p/WNT5A axis regulates the proliferation of prostate cancer cells
1Department of Pathology, The Affiliated Hospital of Qingdao University, Jiangsu Road, South District, Qingdao, 266003 Shandong China.
Background:
Although the fact that long non-coding RNA MCM3AP antisense RNA 1 (MCM3AP-AS1) is oncogenic in several cancers is well documented, very few researchers investigate its expression and function in prostate cancer.
Methods:
Paired prostate cancer samples were selected, and expressions of MCM3AP-AS1, miR-876-5p and WNT5A were examined by qRT-PCR. MCM3AP-AS1 shRNA was transfected into LNCaP and PC-3 cell lines, and then the proliferative activity and apoptosis of cancer cells were detected by CCK-8 assay, EdU assay and flow cytometry analysis, respectively. qRT-PCR and Western blot were used to analyze the changes of miR-876-5p and WNT5A. Luciferase reporter gene assay was employed to determine the regulatory relationship between miR-876-5p and MCM3AP-AS1, miR-876-5p and WNT5A.
Results:
MCM3AP-AS1 was significantly up-regulated in cancerous tissues of prostate cancer samples, positively correlated with the expression of WNT5A, while negatively related with miR-876-5p. After transfection of MCM3AP-AS1 shRNA into prostate cancer cells, the proliferative ability of cancer cells was signally inhibited, but the apoptosis of cancer cells was increased. MCM3AP-AS1 shRNA could reduce the expression of WNT5A on both mRNA and protein levels. Besides, MCM3AP-AS1 was identified as a sponge of miR-876-5p. WNT5A was validated as a target gene of miR- 876-5p.
Conclusion:
MCM3AP-AS1 is abnormally up-regulated in prostate cancer tissues and can modulate the proliferation and apoptosis of prostate cancer cells, which has the potential to be the "ceRNA" to regulate the expression of WNT5A by targeting miR-876-5p.
Insights
Long non-coding RNA MCM3AP antisense RNA 1 (MCM3AP-AS1) is upregulated in prostate cancer, inhibiting proliferation and increasing apoptosis. It acts as a ceRNA, targeting miR-876-5p to regulate WNT5A expression.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Long non-coding RNA MCM3AP antisense RNA 1 (MCM3AP-AS1) is recognized as oncogenic in various cancers.
- Its specific role and expression patterns in prostate cancer remain underexplored.
Purpose of the Study:
- To investigate the expression and functional role of MCM3AP-AS1 in prostate cancer.
- To elucidate the molecular mechanism involving MCM3AP-AS1, miR-876-5p, and WNT5A in prostate cancer progression.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to assess MCM3AP-AS1, miR-876-5p, and WNT5A expression in prostate cancer tissues.
- In vitro functional assays including cell proliferation (CCK-8, EdU) and apoptosis (flow cytometry) after MCM3AP-AS1 knockdown.
- Luciferase reporter assays to confirm regulatory interactions between MCM3AP-AS1, miR-876-5p, and WNT5A.
Main Results:
- MCM3AP-AS1 was significantly upregulated in prostate cancer tissues, correlating positively with WNT5A and negatively with miR-876-5p.
- Knockdown of MCM3AP-AS1 inhibited cancer cell proliferation and induced apoptosis.
- MCM3AP-AS1 functions as a competing endogenous RNA (ceRNA) for miR-876-5p, thereby upregulating WNT5A.
Conclusions:
- MCM3AP-AS1 is aberrantly overexpressed in prostate cancer and influences cancer cell proliferation and apoptosis.
- MCM3AP-AS1 may serve as a potential ceRNA, modulating WNT5A expression via the miR-876-5p pathway in prostate cancer.
Related Concept Videos
Abnormal Proliferation
Canonical Wnt Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Non-Canonical Wnt Signaling Pathways
The Ras Gene
Ras is a...
Induced Pluripotent Stem Cells
Somatic...

